Herpes Simplex Keratitis Drug Market, Global Outlook and Forecast 2022-2028

April 2022 | 60 pages | ID: HC4BC70FA439EN
Market Monitor Global

Abstracts

The human herpes simplex keratitis viruses are one of the leading cause of ophthalmic morbidity globally including cytomegalovirus retinitis in AIDS. The market of herpes simplex keratitis treatment is anticipated to grow significantly in the forecast period as the disease outbreak can cause unilateral corneal blindness worldwide. For herpes simplex keratitis treatment market, the basic understanding of how the virus behaves is helpful for manufacturers to understand the efforts that must still be concentrated on making the best use of new antiviral agents and other modes for avoiding inappropriate treatment.

This report contains market size and forecasts of Herpes Simplex Keratitis Drug in Global, including the following market information:

Global Herpes Simplex Keratitis Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Herpes Simplex Keratitis Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Drug Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Herpes Simplex Keratitis Drug include GlaxoSmithKline, Vectans Pharma, Blistex, Bausch Health, Aurobindo Pharma, Dr. Reddy’s Laboratories, Cipla, Jubilant Cadista and Mylan. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Herpes Simplex Keratitis Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Herpes Simplex Keratitis Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Herpes Simplex Keratitis Drug Market Segment Percentages, by Type, 2021 (%)

• Oral Drug
• Topical Drug

Global Herpes Simplex Keratitis Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Herpes Simplex Keratitis Drug Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Global Herpes Simplex Keratitis Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Herpes Simplex Keratitis Drug Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Herpes Simplex Keratitis Drug revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Herpes Simplex Keratitis Drug revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• GlaxoSmithKline
• Vectans Pharma
• Blistex
• Bausch Health
• Aurobindo Pharma
• Dr. Reddy’s Laboratories
• Cipla
• Jubilant Cadista
• Mylan

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Herpes Simplex Keratitis Drug Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Herpes Simplex Keratitis Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL HERPES SIMPLEX KERATITIS DRUG OVERALL MARKET SIZE

2.1 Global Herpes Simplex Keratitis Drug Market Size: 2021 VS 2028
2.2 Global Herpes Simplex Keratitis Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Herpes Simplex Keratitis Drug Players in Global Market
3.2 Top Global Herpes Simplex Keratitis Drug Companies Ranked by Revenue
3.3 Global Herpes Simplex Keratitis Drug Revenue by Companies
3.4 Top 3 and Top 5 Herpes Simplex Keratitis Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Herpes Simplex Keratitis Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Herpes Simplex Keratitis Drug Players in Global Market
  3.6.1 List of Global Tier 1 Herpes Simplex Keratitis Drug Companies
  3.6.2 List of Global Tier 2 and Tier 3 Herpes Simplex Keratitis Drug Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Herpes Simplex Keratitis Drug Market Size Markets, 2021 & 2028
  4.1.2 Oral Drug
  4.1.3 Topical Drug
4.2 By Type - Global Herpes Simplex Keratitis Drug Revenue & Forecasts
  4.2.1 By Type - Global Herpes Simplex Keratitis Drug Revenue, 2017-2022
  4.2.2 By Type - Global Herpes Simplex Keratitis Drug Revenue, 2023-2028
  4.2.3 By Type - Global Herpes Simplex Keratitis Drug Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Herpes Simplex Keratitis Drug Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Herpes Simplex Keratitis Drug Revenue & Forecasts
  5.2.1 By Application - Global Herpes Simplex Keratitis Drug Revenue, 2017-2022
  5.2.2 By Application - Global Herpes Simplex Keratitis Drug Revenue, 2023-2028
  5.2.3 By Application - Global Herpes Simplex Keratitis Drug Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Herpes Simplex Keratitis Drug Market Size, 2021 & 2028
6.2 By Region - Global Herpes Simplex Keratitis Drug Revenue & Forecasts
  6.2.1 By Region - Global Herpes Simplex Keratitis Drug Revenue, 2017-2022
  6.2.2 By Region - Global Herpes Simplex Keratitis Drug Revenue, 2023-2028
  6.2.3 By Region - Global Herpes Simplex Keratitis Drug Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Herpes Simplex Keratitis Drug Revenue, 2017-2028
  6.3.2 US Herpes Simplex Keratitis Drug Market Size, 2017-2028
  6.3.3 Canada Herpes Simplex Keratitis Drug Market Size, 2017-2028
  6.3.4 Mexico Herpes Simplex Keratitis Drug Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Herpes Simplex Keratitis Drug Revenue, 2017-2028
  6.4.2 Germany Herpes Simplex Keratitis Drug Market Size, 2017-2028
  6.4.3 France Herpes Simplex Keratitis Drug Market Size, 2017-2028
  6.4.4 U.K. Herpes Simplex Keratitis Drug Market Size, 2017-2028
  6.4.5 Italy Herpes Simplex Keratitis Drug Market Size, 2017-2028
  6.4.6 Russia Herpes Simplex Keratitis Drug Market Size, 2017-2028
  6.4.7 Nordic Countries Herpes Simplex Keratitis Drug Market Size, 2017-2028
  6.4.8 Benelux Herpes Simplex Keratitis Drug Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Herpes Simplex Keratitis Drug Revenue, 2017-2028
  6.5.2 China Herpes Simplex Keratitis Drug Market Size, 2017-2028
  6.5.3 Japan Herpes Simplex Keratitis Drug Market Size, 2017-2028
  6.5.4 South Korea Herpes Simplex Keratitis Drug Market Size, 2017-2028
  6.5.5 Southeast Asia Herpes Simplex Keratitis Drug Market Size, 2017-2028
  6.5.6 India Herpes Simplex Keratitis Drug Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Herpes Simplex Keratitis Drug Revenue, 2017-2028
  6.6.2 Brazil Herpes Simplex Keratitis Drug Market Size, 2017-2028
  6.6.3 Argentina Herpes Simplex Keratitis Drug Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Herpes Simplex Keratitis Drug Revenue, 2017-2028
  6.7.2 Turkey Herpes Simplex Keratitis Drug Market Size, 2017-2028
  6.7.3 Israel Herpes Simplex Keratitis Drug Market Size, 2017-2028
  6.7.4 Saudi Arabia Herpes Simplex Keratitis Drug Market Size, 2017-2028
  6.7.5 UAE Herpes Simplex Keratitis Drug Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 GlaxoSmithKline
  7.1.1 GlaxoSmithKline Corporate Summary
  7.1.2 GlaxoSmithKline Business Overview
  7.1.3 GlaxoSmithKline Herpes Simplex Keratitis Drug Major Product Offerings
  7.1.4 GlaxoSmithKline Herpes Simplex Keratitis Drug Revenue in Global Market (2017-2022)
  7.1.5 GlaxoSmithKline Key News
7.2 Vectans Pharma
  7.2.1 Vectans Pharma Corporate Summary
  7.2.2 Vectans Pharma Business Overview
  7.2.3 Vectans Pharma Herpes Simplex Keratitis Drug Major Product Offerings
  7.2.4 Vectans Pharma Herpes Simplex Keratitis Drug Revenue in Global Market (2017-2022)
  7.2.5 Vectans Pharma Key News
7.3 Blistex
  7.3.1 Blistex Corporate Summary
  7.3.2 Blistex Business Overview
  7.3.3 Blistex Herpes Simplex Keratitis Drug Major Product Offerings
  7.3.4 Blistex Herpes Simplex Keratitis Drug Revenue in Global Market (2017-2022)
  7.3.5 Blistex Key News
7.4 Bausch Health
  7.4.1 Bausch Health Corporate Summary
  7.4.2 Bausch Health Business Overview
  7.4.3 Bausch Health Herpes Simplex Keratitis Drug Major Product Offerings
  7.4.4 Bausch Health Herpes Simplex Keratitis Drug Revenue in Global Market (2017-2022)
  7.4.5 Bausch Health Key News
7.5 Aurobindo Pharma
  7.5.1 Aurobindo Pharma Corporate Summary
  7.5.2 Aurobindo Pharma Business Overview
  7.5.3 Aurobindo Pharma Herpes Simplex Keratitis Drug Major Product Offerings
  7.5.4 Aurobindo Pharma Herpes Simplex Keratitis Drug Revenue in Global Market (2017-2022)
  7.5.5 Aurobindo Pharma Key News
7.6 Dr. Reddy’s Laboratories
  7.6.1 Dr. Reddy’s Laboratories Corporate Summary
  7.6.2 Dr. Reddy’s Laboratories Business Overview
  7.6.3 Dr. Reddy’s Laboratories Herpes Simplex Keratitis Drug Major Product Offerings
  7.6.4 Dr. Reddy’s Laboratories Herpes Simplex Keratitis Drug Revenue in Global Market (2017-2022)
  7.6.5 Dr. Reddy’s Laboratories Key News
7.7 Cipla
  7.7.1 Cipla Corporate Summary
  7.7.2 Cipla Business Overview
  7.7.3 Cipla Herpes Simplex Keratitis Drug Major Product Offerings
  7.7.4 Cipla Herpes Simplex Keratitis Drug Revenue in Global Market (2017-2022)
  7.7.5 Cipla Key News
7.8 Jubilant Cadista
  7.8.1 Jubilant Cadista Corporate Summary
  7.8.2 Jubilant Cadista Business Overview
  7.8.3 Jubilant Cadista Herpes Simplex Keratitis Drug Major Product Offerings
  7.8.4 Jubilant Cadista Herpes Simplex Keratitis Drug Revenue in Global Market (2017-2022)
  7.8.5 Jubilant Cadista Key News
7.9 Mylan
  7.9.1 Mylan Corporate Summary
  7.9.2 Mylan Business Overview
  7.9.3 Mylan Herpes Simplex Keratitis Drug Major Product Offerings
  7.9.4 Mylan Herpes Simplex Keratitis Drug Revenue in Global Market (2017-2022)
  7.9.5 Mylan Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Herpes Simplex Keratitis Drug Market Opportunities & Trends in Global Market
Table 2. Herpes Simplex Keratitis Drug Market Drivers in Global Market
Table 3. Herpes Simplex Keratitis Drug Market Restraints in Global Market
Table 4. Key Players of Herpes Simplex Keratitis Drug in Global Market
Table 5. Top Herpes Simplex Keratitis Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Herpes Simplex Keratitis Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Herpes Simplex Keratitis Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Herpes Simplex Keratitis Drug Product Type
Table 9. List of Global Tier 1 Herpes Simplex Keratitis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Herpes Simplex Keratitis Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Herpes Simplex Keratitis Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Herpes Simplex Keratitis Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Herpes Simplex Keratitis Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Herpes Simplex Keratitis Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Herpes Simplex Keratitis Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Herpes Simplex Keratitis Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2023-2028
Table 30. GlaxoSmithKline Corporate Summary
Table 31. GlaxoSmithKline Herpes Simplex Keratitis Drug Product Offerings
Table 32. GlaxoSmithKline Herpes Simplex Keratitis Drug Revenue (US$, Mn), (2017-2022)
Table 33. Vectans Pharma Corporate Summary
Table 34. Vectans Pharma Herpes Simplex Keratitis Drug Product Offerings
Table 35. Vectans Pharma Herpes Simplex Keratitis Drug Revenue (US$, Mn), (2017-2022)
Table 36. Blistex Corporate Summary
Table 37. Blistex Herpes Simplex Keratitis Drug Product Offerings
Table 38. Blistex Herpes Simplex Keratitis Drug Revenue (US$, Mn), (2017-2022)
Table 39. Bausch Health Corporate Summary
Table 40. Bausch Health Herpes Simplex Keratitis Drug Product Offerings
Table 41. Bausch Health Herpes Simplex Keratitis Drug Revenue (US$, Mn), (2017-2022)
Table 42. Aurobindo Pharma Corporate Summary
Table 43. Aurobindo Pharma Herpes Simplex Keratitis Drug Product Offerings
Table 44. Aurobindo Pharma Herpes Simplex Keratitis Drug Revenue (US$, Mn), (2017-2022)
Table 45. Dr. Reddy’s Laboratories Corporate Summary
Table 46. Dr. Reddy’s Laboratories Herpes Simplex Keratitis Drug Product Offerings
Table 47. Dr. Reddy’s Laboratories Herpes Simplex Keratitis Drug Revenue (US$, Mn), (2017-2022)
Table 48. Cipla Corporate Summary
Table 49. Cipla Herpes Simplex Keratitis Drug Product Offerings
Table 50. Cipla Herpes Simplex Keratitis Drug Revenue (US$, Mn), (2017-2022)
Table 51. Jubilant Cadista Corporate Summary
Table 52. Jubilant Cadista Herpes Simplex Keratitis Drug Product Offerings
Table 53. Jubilant Cadista Herpes Simplex Keratitis Drug Revenue (US$, Mn), (2017-2022)
Table 54. Mylan Corporate Summary
Table 55. Mylan Herpes Simplex Keratitis Drug Product Offerings
Table 56. Mylan Herpes Simplex Keratitis Drug Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Herpes Simplex Keratitis Drug Segment by Type in 2021
Figure 2. Herpes Simplex Keratitis Drug Segment by Application in 2021
Figure 3. Global Herpes Simplex Keratitis Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Herpes Simplex Keratitis Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Herpes Simplex Keratitis Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Herpes Simplex Keratitis Drug Revenue in 2021
Figure 8. By Type - Global Herpes Simplex Keratitis Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Herpes Simplex Keratitis Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Herpes Simplex Keratitis Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Herpes Simplex Keratitis Drug Revenue Market Share, 2017-2028
Figure 12. US Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Herpes Simplex Keratitis Drug Revenue Market Share, 2017-2028
Figure 16. Germany Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Herpes Simplex Keratitis Drug Revenue Market Share, 2017-2028
Figure 24. China Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Herpes Simplex Keratitis Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Herpes Simplex Keratitis Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Herpes Simplex Keratitis Drug Revenue, (US$, Mn), 2017-2028
Figure 37. GlaxoSmithKline Herpes Simplex Keratitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Vectans Pharma Herpes Simplex Keratitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Blistex Herpes Simplex Keratitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bausch Health Herpes Simplex Keratitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Aurobindo Pharma Herpes Simplex Keratitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Dr. Reddy’s Laboratories Herpes Simplex Keratitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Cipla Herpes Simplex Keratitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Jubilant Cadista Herpes Simplex Keratitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Mylan Herpes Simplex Keratitis Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)